Chronic Hepatitis
23
2
3
8
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
17.4%
4 terminated out of 23 trials
66.7%
-19.8% vs benchmark
35%
8 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (23)
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
VACcination of LIver Transplantation Candidates
Abbreviated MRI for HCC Surveillance
Hepatic Steatosis and Chronic Hepatitis B Virus
Patient-Centred Innovations for Persons With Multimorbidity - Ontario
Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection
Patient-Centred Innovations for Persons With Multimorbidity - Quebec
Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)
Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)